sorafenib has been researched along with moxifloxacin in 2 studies
Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) |
---|---|---|---|---|---|
6,520 | 730 | 5,251 | 3,157 | 552 | 1,690 |
Protein | Taxonomy | sorafenib (IC50) | moxifloxacin (IC50) |
---|---|---|---|
DNA gyrase subunit B | Staphylococcus aureus | 5.1033 | |
DNA gyrase subunit A | Escherichia coli K-12 | 1.4 | |
DNA gyrase subunit B | Escherichia coli K-12 | 1.4 | |
DNA topoisomerase 4 subunit A | Staphylococcus aureus | 0.8 | |
DNA gyrase subunit A | Staphylococcus aureus | 7.25 | |
DNA gyrase subunit B | Mycobacterium tuberculosis H37Rv | 8.525 | |
DNA gyrase subunit A | Mycobacterium tuberculosis H37Rv | 8.66 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for sorafenib and moxifloxacin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for sorafenib and moxifloxacin
Article | Year |
---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |